Welcome to our dedicated page for Avantor news (Ticker: AVTR), a resource for investors and traders seeking the latest updates and insights on Avantor stock.
Avantor, Inc. (NYSE: AVTR) is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. This news page aggregates company announcements, earnings updates and other disclosures so readers can follow how Avantor’s operations, portfolio and governance evolve over time.
Recent news releases describe Avantor’s participation in investor conferences, quarterly earnings reports, leadership and board appointments, and product and service developments. Examples include announcements about the timing of quarterly and full-year earnings releases and related conference calls, as well as participation in events such as the J.P. Morgan Healthcare Conference. These items provide context on how the company communicates with the investment community and presents its financial performance.
Product- and operations-focused news highlights areas such as bioprocessing, biomanufacturing and laboratory services. Avantor has reported the launch of a sterile sampling platform and PUPSIT assemblies for bioprocessing, the development of a biodegradable viral inactivation detergent recognized with an Edison Patent Award, and the expansion of its Centralized Service Center model with a facility serving the Greater Boston area. These updates illustrate how the company positions its tools and services within scientific and industrial workflows.
Corporate governance news includes the appointment of new directors and senior executives, such as additions to the Board of Directors and the creation of an Executive Vice President and Chief Operating Officer role. Together, these news items offer insight into Avantor’s strategic priorities, leadership changes and ongoing initiatives. Investors, analysts and industry participants can use this page to monitor company communications and official announcements over time.
Avantor has declared a quarterly cash dividend of $0.78 per share for its 6.250% Series A Mandatory Convertible Preferred Stock, representing a yield of 1.560%. The dividend will be paid on May 17, 2021, to shareholders on record as of April 1, 2021. This move underscores Avantor's commitment to returning value to shareholders and reflects confidence in its business model amidst ongoing global challenges.
Avantor (NYSE: AVTR) announced its acquisition of Ritter GmbH for approximately €890 million in an all-cash deal, subject to adjustments and performance milestones. Ritter is a leading manufacturer of robotic and liquid handling consumables with a market potential of nearly $7 billion. This acquisition aims to enhance Avantor's offerings in the biopharma and healthcare sectors, and is expected to be accretive to adjusted EPS immediately upon closing. The deal will be financed through available cash and term loans, with a closing anticipated in Q3 2021.
Avantor, Inc. (NYSE: AVTR) will announce its Q1 2021 financial results on April 28, 2021, after market closure. A conference call is scheduled for 5:00 p.m. ET the same day, allowing investors to discuss the results. Interested participants can join via phone or access a live webcast through the company's website. Avantor, a Fortune 500 company, provides essential products and services across the biopharma, healthcare, and advanced technologies sectors, supported by a global presence that serves over 225,000 customer locations worldwide.
Avantor (NYSE: AVTR) announced a credit rating upgrade from Moody's Investor Services to 'Ba3' with a stable outlook, following similar upgrades from Fitch Ratings and S&P Global Ratings. This rating reflects Avantor's strong performance and resilience during challenging market conditions. The company's business model remains essential to its customers across various sectors, including biopharma and advanced technologies. This upgrade is expected to enhance investor confidence and potentially lower borrowing costs, further supporting Avantor's growth initiatives.
Avantor (NYSE: AVTR) will engage in a virtual fireside chat at the Raymond James 42nd Annual Institutional Investor Conference on March 1, 2021, starting at 4:40 p.m. Eastern Time. Michael Stubblefield, President and CEO, will represent the company. Investors can access the live webcast via Avantor's investor relations page, with a replay available until March 31, 2021. Avantor is a leading provider of mission-critical products and services across biopharma, healthcare, and advanced technologies, serving over 225,000 customer locations in 180 countries.
Avantor, Inc. (NYSE: AVTR) announced a significant upgrade in its credit rating to 'BB+' with a stable outlook by S&P Global Ratings on February 10, 2021. The company's CFO, Thomas Szlosek, expressed satisfaction with this acknowledgment, highlighting their strong operational performance amidst a challenging market environment. Avantor's integrated business model has been crucial in supporting customers across various research phases. The company serves over 225,000 customer locations globally, underscoring its extensive reach and infrastructure in the life sciences and advanced technologies sectors.
Avantor, Inc. (NYSE: AVTR) reported strong financial results for Q4 and the full year 2020, showcasing resilience in a challenging environment. Q4 net sales reached $1.791 billion, up 17.5% YoY, with organic growth of 14.9%. The company generated $286 million in free cash flow. For the full year, net sales were $6.394 billion, marking a 5.8% increase, and free cash flow surged 187% to $868.2 million. Adjusted EPS rose to $0.29 in Q4, while full-year adjusted EPS increased to $0.89. The company is well-positioned as a critical partner in fighting diseases, including COVID-19.
Avantor, Inc. (NYSE: AVTR) has declared a quarterly cash dividend of $0.78 per share for its 6.250% Series A Mandatory Convertible Preferred Stock, representing a yield of 1.560%. This dividend will be payable on February 15, 2021 to shareholders on record as of February 1, 2021. The company emphasizes its commitment to enhancing shareholder value while maintaining a strong global presence in the life sciences and advanced materials sectors.
Avantor, a global provider of mission-critical products and services, will announce its fourth quarter and full year 2020 financial results after the market closes on February 3, 2021. A conference call to discuss these results will be held at 5:00 p.m. ET on the same day. Participants can join via phone or through a live webcast on the company's website. Avantor serves more than 225,000 customer locations globally, operating in key industries such as biopharma and healthcare.
Avantor (NYSE: AVTR) announced preliminary unaudited revenues for Q4 2020, estimating approximately $1.79B, reflecting an organic revenue growth of ~15%. The free cash flow is estimated at over $270M, significantly higher than $74.9M in Q4 2019. The results, to be finalized soon, align with the company's ongoing performance in life sciences and advanced materials. Management will present 2021 revenue expectations at the J.P. Morgan Healthcare Conference. Notably, these preliminary results are unaudited and may change upon final review.